Literature DB >> 19949971

Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo.

Dominic J Wells1.   

Abstract

Non-viral vectors are less efficient than the use of viral vectors for delivery of genetic material to cells in vitro and especially in vivo. However, viral vectors involve the use of foreign proteins that can stimulate both the innate and acquired immune response. In contrast, plasmid DNA can be delivered without carrier proteins and is non-immunogenic. Plasmid gene delivery can be enhanced by the use of physical methods that aid the passage of the plasmid through the cell membrane. Electroporation and microbubble-enhanced ultrasound are two of the most effective physical delivery methods and these can be applied to a range of different cell types in vitro and a broad range of tissues in vivo. Both techniques also have the advantage that, unlike viral vectors, they can be used to target specific tissues with systemic delivery. Although electroporation is often the more efficient of the two, microbubble-enhanced ultrasound causes less damage and is less invasive. This review provides an introduction to the methodology and summarises the range of cells and tissues that have been genetically modified using these techniques.

Mesh:

Substances:

Year:  2009        PMID: 19949971     DOI: 10.1007/s10565-009-9144-8

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  17 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.

Authors:  Natalya Rapoport; Kweon-Ho Nam; Roohi Gupta; Zhongao Gao; Praveena Mohan; Allison Payne; Nick Todd; Xin Liu; Taeho Kim; Jill Shea; Courtney Scaife; Dennis L Parker; Eun-Kee Jeong; Anne M Kennedy
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

Review 3.  Functional lipids and lipoplexes for improved gene delivery.

Authors:  Xiao-Xiang Zhang; Thomas J McIntosh; Mark W Grinstaff
Journal:  Biochimie       Date:  2011-05-20       Impact factor: 4.079

4.  Phase transitions of nanoemulsions using ultrasound: experimental observations.

Authors:  Ram Singh; Ghaleb A Husseini; William G Pitt
Journal:  Ultrason Sonochem       Date:  2012-03-01       Impact factor: 7.491

Review 5.  Sonoporation: Gene transfer using ultrasound.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi
Journal:  World J Methodol       Date:  2013-12-26

6.  Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo.

Authors:  Olga Zolochevska; Xueqing Xia; B Jill Williams; Alistair Ramsay; Shulin Li; Marxa L Figueiredo
Journal:  Hum Gene Ther       Date:  2011-09-01       Impact factor: 5.695

7.  Dual gene expression in embryoid bodies derived from human induced pluripotent stem cells using episomal vectors.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi
Journal:  Tissue Eng Part A       Date:  2014-12       Impact factor: 3.845

8.  Stimuli responsive charge-switchable lipids: Capture and release of nucleic acids.

Authors:  Joseph S Hersey; Caroline M LaManna; Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Phys Lipids       Date:  2016-02-16       Impact factor: 3.329

9.  Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair.

Authors:  Nadav Kimelman-Bleich; Gadi Pelled; Yoram Zilberman; Ilan Kallai; Olga Mizrahi; Wafa Tawackoli; Zulma Gazit; Dan Gazit
Journal:  Mol Ther       Date:  2010-09-21       Impact factor: 11.454

10.  In vivo gene delivery with L-tyrosine polyphosphate nanoparticles.

Authors:  Andrew J Ditto; John J Reho; Kush N Shah; Justin A Smolen; James H Holda; Rolando J Ramirez; Yang H Yun
Journal:  Mol Pharm       Date:  2013-04-08       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.